Z Geburtshilfe Neonatol 2024; 228(03): 290-293
DOI: 10.1055/a-2247-5792
Case Report

Placenta Invasion Anomaly without Placenta Previa in the First Trimester of Pregnancy and its Conservative Management: A Case Presentation

Aytaj Jafarzade
1   Koru Health Group, Gynecology and Obstetrics Department, Ankara, Turkey
› Author Affiliations


Diagnosing placenta accreta spectrum (PAS) is rather difficult in the first trimester of pregnancy. Especially if the localization of the placenta is not in and around the cervical canal, this may not attract the attention of obstetricians. Early diagnosis can decrease bleeding during curettage or miscarriage, but there are no guidelines regarding its diagnosis in the first trimester. In addition, there is insufficient evidence-based knowledge in the literature on the management and treatment of PAS without placenta previa. In this article, conservative treatment without hysterectomy of a patient diagnosed with PAS in first trimester was presented.

Publication History

Received: 06 November 2023

Accepted after revision: 07 January 2024

Article published online:
07 February 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

  • References

  • 1 Usta IM, Hobeika EM, Musa AA. et al. Placenta previa-accreta: risk factors and complications. Am J Obstet Gynecol 2005; 193: 1045-1049
  • 2 Iacovelli A, Liberati M, Khalil A. et al. Risk factors for abnormally invasive placenta: a systematic review and meta-analysis. J Matern Fetal Neonatal Med 2018; 22: 1-11
  • 3 Calì G, Timor-Tritsch IE, Palacios-Jaraquemada J. et al. Outcome of Cesarean scar pregnancy managed expectantly: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2018; 51: 169-175
  • 4 Silver RM. Placenta accreta spectrum: Clinical features, diagnosis, and potential consequences. Available from: https://www.uptodate.com/contents/placenta-accreta-spectrum-clinical-features-diagnosis-and-potential-consequences
  • 5 Wang YL, Weng SS, Huang WC. First-trimester abortion complicated with placenta accreta: A systematic review. Taiwan J Obstet Gynecol 2019; 58: 10-14
  • 6 Khong TY. The pathology of placenta accreta, a worldwide epidemic. J Clin Pathol 2008; 61: 1243
  • 7 Carusi D, Fox KA, Lyell DJ. et al. Placenta accreta spectrum without placenta previa. Obstet Gynecol 2020; 136: 458-465
  • 8 Papadakis JC, Christodoulou N, Papageorgiou A. et al. Placenta percreta presenting in the first trimester and resulting in severe consumption coagulopathy and hysterectomy: a case report. Clin Exp Obstet Gynecol 2008; 35: 225-226
  • 9 Matsubara S, Takahashi H, Takei Y. Magnetic resonance imaging for diagnosis of placenta accreta spectrum disorders: still useful for real-world practice. Am J Obstet Gynecol 2018; 219: 312-313
  • 10 Sentilhes L, Kayem G, Chandraharan E. et al. FIGO consensus guidelines on placenta accreta spectrum disorders: conservative management. Int J Gynaecol Obstet 2018; 140: 291-298
  • 11 Einerson BD, Branch DW. Surgical management of placenta accreta spectrum. Clin Obstet Gynecol 2018; 61: 774-782
  • 12 Farasatinasab M, Moghaddas A, Dashti-Khadivaki S. et al. Management of abnormal placenta implantation with methotrexate: a review of published data. Gynecol Obstet Invest 2016; 81: 481-496
  • 13 Dimitrova I, Jauniaux E, Zosmer N. et al. Development of a training program for the ultrasound screening of placenta accreta spectrum disorders. Int J Gynaecol Obstet 2019; 147: 73-77